GAD2 on Chromosome 10p12 Is a Candidate Gene for Human Obesity |
| |
| Authors: | Philippe Boutin Philippe Boutin Philippe Boutin Philippe Boutin Philippe Boutin Philippe Boutin Philippe Boutin Philippe Boutin Philippe Boutin Philippe Boutin Philippe Boutin |
| |
| Affiliation: | 1
Institute of Biology–Centre National de la Recherche Scientifique, Pasteur Institute
Lille
France;2
University Hospital of Lille
Lille
France;3
Department of Medicine, University of Washington
Seattle, Washington
United States of America;4
Institut National de la Santé et de la Recherche Médicale (INSERM), Paul Brousse Hospital
Villejuif
France;5
Paris VI University and INSERM “Avenir,” Department of Nutrition, Hôtel Dieu Hospital
Paris
France;6
Hammersmith Genome Centre and Department of Genomic Medicine, Imperial College
London
United Kingdom |
| |
| Abstract: | The gene GAD2 encoding the glutamic acid decarboxylase enzyme (GAD65) is a positional candidate gene for obesity on Chromosome 10p11–12, a susceptibility locus for morbid obesity in four independent ethnic populations. GAD65 catalyzes the formation of γ-aminobutyric acid (GABA), which interacts with neuropeptide Y in the paraventricular nucleus to contribute to stimulate food intake. A case-control study (575 morbidly obese and 646 control subjects) analyzing GAD2 variants identified both a protective haplotype, including the most frequent alleles of single nucleotide polymorphisms (SNPs) +61450 C>A and +83897 T>A (OR = 0.81, 95% CI [0.681–0.972], p = 0.0049) and an at-risk SNP (−243 A>G) for morbid obesity (OR = 1.3, 95% CI [1.053–1.585], p = 0.014). Furthermore, familial-based analyses confirmed the association with the obesity of SNP +61450 C>A and +83897 T>A haplotype (χ2 = 7.637, p = 0.02). In the murine insulinoma cell line βTC3, the G at-risk allele of SNP −243 A>G increased six times GAD2 promoter activity (p < 0.0001) and induced a 6-fold higher affinity for nuclear extracts. The −243 A>G SNP was associated with higher hunger scores (p = 0.007) and disinhibition scores (p = 0.028), as assessed by the Stunkard Three-Factor Eating Questionnaire. As GAD2 is highly expressed in pancreatic β cells, we analyzed GAD65 antibody level as a marker of β-cell activity and of insulin secretion. In the control group, −243 A>G, +61450 C>A, and +83897 T>A SNPs were associated with lower GAD65 autoantibody levels (p values of 0.003, 0.047, and 0.006, respectively). SNP +83897 T>A was associated with lower fasting insulin and insulin secretion, as assessed by the HOMA-B% homeostasis model of β-cell function (p = 0.009 and 0.01, respectively). These data support the hypothesis of the orexigenic effect of GABA in humans and of a contribution of genes involved in GABA metabolism in the modulation of food intake and in the development of morbid obesity. |
| |
| Keywords: | |
|
| 点击此处可从《PLoS Biology》浏览原始摘要信息 |
|
点击此处可从《PLoS Biology》下载全文 |
|
